|
|
 |
|
Viewing report
|
|
|
|
Amarin Corporation plc (AMRN) - Financial and Strategic SWOT Analysis Review
GlobalData, Aug 2011, Pages: 42
Amarin Corporation plc (AMRN) - Financial and Strategic SWOT Analysis Review
Summary
Amarin Corporation plc (Amarin) is a biopharmaceutical company. The company focuses on the development of products in cardiovascular therapeutic area. The company’s lead program AMR101, for the treatment of hypertriglyceridemia and Huntington’s disease, is currently being studied in two concurrently run pivotal Phase 3 trials. The company's various cardiovascular programs capitalize its expertise in the field of lipid science and the known therapeutic benefits of essential fatty acids in cardiovascular disease. The company operates in the UK, Ireland, and Rest of World. The company has its research and development headquartered in Mystic Connecticut, the US. Amarin is headquartered at London in England, the UK.
Amarin Corporation plc Key Recent Developments…
May 10, 2011 Amarin Reports Net Income Of $18.3m For Q1 2011
Mar 16, 2011 Amarin Reports Net Loss Of $249.6m For 2010
Feb 02, 2011 Amarin Appoints Paul Huff As Chief Commercial Officer
Nov 18, 2010 Amarin Names Kristine Peterson To Board Of Directors
Nov 10, 2010 Amarin Announces Senior Management Changes
This comprehensive SWOT profile of Amarin Corporation plc provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Customers who bought this item also bought
Amarin Corporation plc - Product Pipeline Review - H2 2011
Hikma Pharmaceuticals PLC (HIK) - Financial and Strategic SWOT Analysis Review
Amarin Corporation plc - Product Pipeline Review - Q4 2010
Amarin Corporation plc - Product Pipeline Review - Q4 2010
Acura Pharmaceuticals, Inc. (ACUR) - Financial and Strategic SWOT Analysis Review
Momenta Pharmaceuticals, Inc. (MNTA) - Financial and Strategic SWOT Analysis Review
BioCryst Pharmaceuticals, Inc. (BCRX) - Financial and Strategic SWOT Analysis Review
MAP Pharmaceuticals, Inc. (MAPP) - Financial and Strategic SWOT Analysis Review
Avexa Limited (AVX) - Financial and Strategic SWOT Analysis Review
Infinity Pharmaceuticals, Inc. (INFI) - Financial and Strategic SWOT Analysis Review
|
|
|
|
